Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [Phase 2]
Phase 2 study evaluating unrelated cord blood transplantation using tacrolimus and sirolimus for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders [Phase 2]
A Phase 2 trial testing nonmyeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors for multiple hematologic dis…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 1, Phase 2]
A clinical trial update for a combination chemotherapy approach in relapsed or refractory Hodgkin lymphoma, spanning Phase 1 and Phase 2, wi…
-
CLINICAL_TRIALS withdrawal · 2016-07-14Clinical Trial Update: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies [Phase 2]
A Phase 2 clinical trial evaluating single or double donor umbilical cord blood transplant for high-risk hematologic malignancies has been w…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL) [Phase 3]
Phase III randomized, double-blind, placebo-controlled multicenter trial evaluating panobinostat as maintenance therapy in Hodgkin lymphoma …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy for newly diagnosed stage I or stage II Hodgkin's lymphoma; the study stat…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies [Phase 1]
Phase 1 safety study evaluating a natural killer (NK) cell line for hematologic cancers has completed, assessing its use against leukemia, l…
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma
This clinical trial update examines how social inequalities affect participation and daily activity in children and adolescents with Hodgkin…
-
CLINICAL_TRIALS research · 2016-06-14Clinical Trial Update: Treatment for Classical Hodgkin Lymphoma in Children and Adolescents [NA]
This entry indicates an ongoing clinical trial evaluating treatment for classical Hodgkin lymphoma in children and adolescents, currently re…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors [EARLY_Phase 1]
Early-phase 1 clinical trial update for nelfinavir in gammaherpesvirus-related tumors, noting termination of the study despite investigation…
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Clinical trial update describes research on using microRNAs as a diagnostic tool to identify hematological malignancies and predict therapeu…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma
This Clinical Trial Update reports on biomarker analyses in blood and tissue samples from patients with Epstein-Barr Virus-positive Hodgkin …
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma
This completed clinical trial evaluated protein biomarker levels in tissue samples from young patients with low-risk Hodgkin lymphoma to ide…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
A Duke University registry study evaluating T-cell depleted allogeneic non-myeloablative stem cell transplantation for hematologic cancers h…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies [Phase 2]
Phase 2 clinical trial update on mismatched family member donor stem cell transplantation in children and young adults with high-risk hemato…
-
FDA approval · 2016-04-28FDA Approved: CARMUSTINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Carmustine submitted by Heritage Pharmaceuticals Inc. (doing business as Avet Pharmaceutical…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Quality of Life Among Survivors of Hodgkin Lymphoma
A completed clinical trial assessing quality of life among survivors of Hodgkin lymphoma. The study status is COMPLETED.
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [Phase 2]
Phase 2 clinical trial investigating thiotepa-based conditioning for allogeneic stem-cell transplantation in lymphoid malignancies, includin…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [Phase 2]
Phase 2 trial evaluating treosulfan-based conditioning for allogeneic stem cell transplantation in lymphoid malignancies is being updated. T…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment. [Phase 2]
Phase 2 study of everolimus (RAD001) in relapsed/refractory Hodgkin lymphoma after high-dose chemotherapy/autologous stem cell transplant or…
-
CLINICAL_TRIALS research · 2016-03-30Clinical Trial Update: Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma [Phase 3]
This is a Phase 3 randomized trial comparing G-CSF alone versus intermediate-dose Ara-C plus G-CSF mobilization in patients with Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib plus gemcitabine hydrochloride in relapsed or refractory Hodgkin lymphoma has completed and posted resul…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of POL6326 for mobilization and transplant in hematologic malignancies has completed…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer [Phase 2]
Phase 2 trial update of Basiliximab to prevent graft-versus-host disease after nonmyeloablative allogeneic transplantation in blood cancers;…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of ofatumumab with the ESHAP regimen for Hodgkin lymphoma has completed.